Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

MDS 2020 | Clonal hematopoiesis & MDS

David Steensma, MD, Dana-Farber Cancer Institute, Boston, MA, discusses myelodysplastic syndromes (MDS) and clonal hematopoiesis. This interview took place at the 2nd Regional Symposium on Myelodysplastic Syndromes (MDS 2020), held in Tel Aviv, Israel.